StockWatch
·

Aeroflex Industries Ltd Q2 FY27 Results

AEROFLEXQ2 FY27 Results
Filing
Result:Very Good· Market: Surged#Broad based#Margin expansion#One-off gain

Outlook: Optimistic · Guidance: None

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue207.3642.6%87.0%
Total Income207.6842.3%87.0%
Expenditure158.0831.6%73.1%
PBT49.6191.6%151.6%
Net Profit36.5694.5%156.8%
OPM24.27%1.23pp0.93pp
NPM17.60%4.73pp4.78pp
EPS2.7694.4%150.9%
View full financials

Adjusted PAT grew ~99% YoY on revenue +87% (6-quarter high) with EBITDA margin expanding to ~24.4% from ~23.3%, a genuine core-business-driven standout even after stripping the one-off depreciation-method gain from the headline 157% PAT print.

AEROFLEX INDUSTRIES · Q2 FY27 · THE VERDICT

Record Quarter Leans on Depreciation Benefit; Capex Execution Is the Bet

Reported PAT jumped 157% to ₹36.6 Cr, but an ₹8.41 Cr accounting benefit inflates the organic run-rate. The real story is whether management can execute ₹202 Cr capex and fill capacity profitably.

02 Nov 2026 · 6 min read
Q2 Revenue

₹207.4 Cr

+87% YoY, +42.6% QoQ

Q2 Reported PAT

₹36.6 Cr

+157% YoY, +94.5% QoQ

Depreciation benefit (WDV→SLM)

₹8.41 Cr

One-time method change

Q2 Organic PAT (normalized)

~₹28.2 Cr

Excludes depreciation benefit

Aeroflex delivered a record quarter on headline numbers—₹207.4 crore revenue, ₹36.6 crore PAT. But the earnings quality picture requires unpacking. The company switched its depreciation method in Q1 FY27 from Written Down Value (WDV) to Straight Line Method (SLM), a change that reduced depreciation expense by ₹8.41 crore in Q2. Strip that out, and organic PAT is closer to ₹28.2 crore—still a solid 48% YoY growth, but not the step-change the headline suggests. This is disclosed and normalized in guidance, so it's transparent, but it frames what management meant by 'margin expansion.' The real story is not the quarter itself, which proved resilient, but whether the company can execute a ₹202 crore capacity bet and fill it profitably.

What the quarter delivered

Underlying execution was solid. EBITDA rose to ₹50.34 crore (24.27% margin), beating the Q1 guidance target of 23%. Revenue growth (87% YoY, 42.6% QoQ) is authentic—driven by volume, not accounting. Two segments powered the growth. First: liquid cooling skids for data center liquid cooling systems. This vertical did not exist two years ago and now represents ₹84.9 crore (24% of H1 revenue), with a $54 billion global market growing 30%+ annually. Second: metal hose assemblies, expanding 40% YoY into international markets (the largest hose market globally). The hose capacity expansion to 20 million meters is complete. On capacity: the company has commissioned 12,000 of 15,000 planned skid assembly units and remains on track to hit 15,000 by December 2026.

Q2 FY27, ₹ Cr
013.6627.3340.9936.6Reported PAT8.41Depreciation benefit28.2Organic PAT
Reported PAT includes ₹8.41 Cr benefit from depreciation method change (WDV→SLM). Organic PAT, normalized for this one-time item, is approximately ₹28.2 Cr.
Key claims from the call vs. what the numbers confirm

Record quarterly revenue ₹207.4 Cr, 87% YoY growth

Confirmed. Growth spread across skids, hose, assemblies—not concentrated.

Supported

EBITDA margin 24.3%, up 129 bps YoY

Q2 EBITDA margin 24.27%, beats Q1 guidance of 23%. Organic improvement visible.

Supported

Liquid cooling now 24% of H1 revenue

H1 ₹353.66 Cr × 24% = ₹84.9 Cr. Verified as 'significant milestone.'

Supported

Skid capacity ramp: 12,000 commissioned, 15,000 by Dec 2026

12,000 commissioned, tracking on time. Aligns with Q1 guidance timeline.

Supported

FY27 guidance ₹715–₹725 Cr (60% growth)

H1 ₹353.66 Cr; requires H2 ₹361–₹371 Cr. Achievable if Q3–Q4 sustain Q2 run-rate.

Reasonable

FY30 target ₹1,500 Cr at 25%+ EBITDA margins

Credible mechanism (doubled capacity by Mar 2028, 80% utilization), but hinges on capex execution and customer concentration de-risking.

Credible but execution-heavy

What changed on this call

Q1 gave only EBITDA margin guidance and capacity timelines; Q2 crystallized the full-year narrative. First: explicit FY27 revenue guidance of ₹715–₹725 crore (60% growth), anchoring street expectations. Second: the skid business FY27 target raised from ₹125 crore (the original plan) to ₹150–₹200 crore—the company already runs at ₹125 crore run-rate in Q2 alone. Third: management introduced a long-term milestone: FY30 revenue ~₹1,500 crore at 25%+ EBITDA margins, reframing the company from a traditional hose supplier to a data center infrastructure play. Fourth: the liquid cooling vertical was isolated and quantified as 24% of H1 revenue, a structural shift not previously disclosed. Finally: management announced the merger of Hyd-Air Engineering (₹11.5 crore subsidiary) for cost consolidation, expecting 'a couple of percentage points' margin benefit—vague but positioned as accretive.

The pivot: capacity ramp and utilization

The core debate on this call was not about current profitability—that's proven—but whether management can execute a ₹202 crore capex plan and fill incremental capacity profitably. Current utilization is only 40–50% of total capacity in FY27; management expects 80% by FY28. This is binary. If capacity fills as guided, the FY30 ₹1,500 crore target at 25%+ margins becomes credible. If utilization stalls or competition erodes pricing, capex becomes value-destructive. On the call, analysts pressed hard: the domestic project pipeline (ports, data centers, firefighting) is real, but international SFN (skid flow network) designs remain in sampling stage with one U.S. multinational customer, with no timeline to commercial orders. Management held firm on capex but deferred specifics to future quarterly reviews. The lack of near-term international order visibility is the swing factor.

The bull case vs. the bear case

The bull-bear ledger
  • Structural tailwind: liquid cooling TAM $54 Bn, growing 30%+ CAGR.

  • Demonstrated execution: beat EBITDA guidance (24.27% vs 23% target), capacity ramp on track (12k of 15k commissioned).

  • Integrated provider with pricing power: skid realisations ₹1.5–₹5 Cr per unit depending on complexity.

  • FY27 60% growth credible: H1 ₹353.66 Cr implies H2 ₹361–₹371 Cr, achievable at current trajectory.

  • Customer concentration: 24% of revenue from one U.S. multinational on exclusive India deal. Extreme risk if customer delays.

  • Capex execution unproven: ₹202 Cr across brownfield and greenfield sites. Any delays push utilization ramp to FY29.

  • International timelines vague: SFN designs in sampling for 2–3 months. Regulatory/certification timelines 'difficult to forecast.' No orders signed.

  • Depreciation benefit inflates reported PAT: Organic growth 48% YoY, not 157%. Normalise for comparability.

  • Domestic utilization only 40–50% FY27. If slower-than-expected fill, capex ROI deteriorates.

  • Freight cost headwinds on international shipments. Pricing power limited vs. Vertiv, Aspen Systems.

Risks, ranked by how much they should concern a holder

Capex execution: ₹202 Cr across brownfield (Taloja) and greenfield sites. Delays or overruns push phase 2 completion past Mar 2028.

High

If phase 2 misses, capacity ramp slips to FY29 and FY29–FY30 revenue targets become unachievable. ROI on ₹202 Cr deteriorates with each quarter of delay.

Customer concentration: 24% of H1 revenue (₹84.9 Cr annualized) from one U.S. multinational on exclusive India arrangement.

High

Single-customer concentration at ~25% of revenue is extreme. If customer reduces orders, defaults on payment, or shifts to alternative suppliers, growth narrative collapses. International alternatives still in sampling.

Capacity utilization ramp only 40–50% FY27; if demand materialises slower, incremental capacity underdeployed and margin-dilutive.

Medium

At 40–50% utilization, capex becomes inefficient. Domestic project pipeline is real but timelines unpredictable. If utilization stalls <60% through FY28, margin compression follows.

International SFN expansion in early sampling stage (2–3 months in). No orders signed; certification/regulatory timelines 'difficult to forecast.'

Medium

International revenue is baked into FY29–FY30 targets. If approvals take longer than expected (common for high-performance DC equipment), international revenue slips by 2–3 quarters.

Freight and logistics cost inflation on international shipments; pricing power limited in competitive markets.

Low

Mentioned as concern but unquantified. Likely hedgeable via customer pricing. Aeroflex has strong brand in data center but competes with Vertiv, Aspen Systems.

Hyd-Air merger synergies vague ('couple of percentage bps'). Either modest or management underselling integration complexity.

Low

If synergies are 0.5–1% EBITDA, accretive. If <0.5%, neutral. Vague guidance suggests either caution or modest scope.

How the street is positioned

Aeroflex is at ₹513.80, down 16.22% from its all-time high of ₹613.25 but up 225.19% from its 52-week low of ₹158. The stock trades below its 20-day (₹519.12) and 50-day (₹523.88) moving averages, signaling consolidation, but well above its 200-day (₹377.29), keeping the long-term trend intact. RSI is neutral (50.1), and volume is increasing—a sign of institutional interest. Price action after the Q2 result has been muted, neither ripping nor crashing. This suggests the market has priced in a beat but remains skeptical of the long-term capex narrative. More telling: foreign institutional investors are accumulating aggressively. FII ownership jumped from 1.49% in Q4 FY26 to 3.60% in Q1 FY27 (a 2.11 percentage-point gain), while domestic institutions trimmed from 3.80% to 1.47% (a 2.33 pp loss). This divergence is significant—international money sees the liquid cooling thesis; domestic money is cautious, possibly due to execution concerns. Promoter holding is stable at 65.47% (no insider capitulation). Bulk deal activity (last 6 months) has been neutral—mix of buyers and sellers around ₹550–₹556—with no promoter/insider-linked names flagged for distressed selling. The muted price action combined with FII accumulation suggests the market is waiting for proof of concept: either a signed international order or evidence that domestic utilization is ramping faster than 40–50%.

What to watch next

Three concrete catalysts that resolve the debate
  • 1 · December 2026 — Phase 1 skid capacity operationalized at 15,000 units/year

    The first near-term execution test. If the Taloja facility comes online on schedule, capex discipline spikes and long-term credibility follows. Any delays cascade into FY28 guidance misses.

  • 2 · H2 FY27 (by Mar 2027) — International SFN orders signed

    The thesis-critical catalyst. Management said it's 'targeting closure soon' on international SFN orders. If even one major multinational OEM (outside the current U.S. customer) signs by Q4 FY27, customer concentration risk de-risks sharply and FY28–FY29 growth becomes multi-customer. If no orders by March 2027, international expansion slips to FY28 and capex bet becomes riskier.

  • 3 · March 2028 — Phase 2 capex complete; capacity at 30,000 skids, 30M hose meters

    The endgame test. By Mar 2028, the company should have doubled capacity. The question: at what utilization % and EBITDA margin? If utilization <60% or EBITDA margins compress below 24%, the capex bet has been inefficient. Both outcomes invalidate the FY30 ₹1,500 Cr target.

Aeroflex delivered a record quarter with organic growth visible underneath the accounting benefit. Capacity ramp is on track, and management has demonstrated execution discipline (beat EBITDA guidance, capacity milestones achieved on time). The business is real, the TAM is structural, and the competitive moat (integrated skid + hose provider) is credible. But this is a step-change only if capex execution delivers. The risk/reward is balanced, tilted slightly to the bull case because FII money is accumulating (a signal that international investors see the thesis) and the stock is only 16% off its all-time high (so much upside is NOT yet priced in).

Holders should focus on the single metric that resolves the debate: skid utilization % growth and international order bookings (not profit growth, which is assured). If December 2026 capacity comes in as promised AND H2 FY27 yields at least one international order, the ₹1,500 Cr FY30 target becomes plausible. If either slips, the capex bet is unravelling and downside is real. Until then, this is a credible franchise with binary execution risk. Watch utilization.

Informational and educational content only. Not investment advice.